%PDF-1.7
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-06-15T12:14:31-05:00
2017-06-15T12:14:31-05:00
2017-06-15T12:14:31-05:00
Adobe InDesign CC 2017 (Windows)
uuid:af62bab7-676e-4c80-9585-2216ce526f89
xmp.did:5e04fea8-b29b-c643-9d13-a71790cd99a6
xmp.id:df8fefb4-6b0e-484a-a4d8-d4895ce4e143
proof:pdf
xmp.iid:4c74f412-fb10-e34d-a052-958099cef5a1
xmp.did:b3a9abe6-6576-2348-9c06-0550fb4335f3
xmp.did:5e04fea8-b29b-c643-9d13-a71790cd99a6
default
converted
from application/x-indesign to application/pdf
Adobe InDesign CC 2017 (Windows)
/
2017-06-15T12:14:31-05:00
application/pdf
Adobe PDF Library 15.0
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[0.0 0.0 581.102 765.354]/Type/Page>>
endobj
33 0 obj
<>stream
q
/GS0 gs
0 TL/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0.04 Tc -0.04 Tw 9 0 0 9 529.2283 32.9076 Tm
(81)Tj
0 Tc 0.264 Tw -53.449 71.984 Td
[(Aunque )-1.3 (la anemia )-1.6 (perniciosa )-0.6 (es generalmente )-2.7 (raro, )0.8 (el )]TJ
-0.069 Tw 0 -1 TD
[(diagn\363stico )-1.1 (es m\341s frecuente )-2.2 (en )-1 (el )-0.6 (anciano )-1.7 (en )-1.1 (combinaci\363n )]TJ
0.152 Tw T*
[(con otras enfermedades )-1.7 (autoin)-1.4 (munes, )-1.7 (como ocurri\363 con )]TJ
0.191 Tw T*
[(nuestro )-1.1 (paciente )-2.9 (portador de )-1 (vit\355ligo, )-1 (si el )-0.7 (paciente )-2.9 (no )]TJ
0.025 Tw T*
[(ha )-1.4 (tenid)-1.6 (o historia )-1.2 (de )-1.1 (gastrectom)-1 (\355a )-1.2 (se )-0.8 (tiene )-2.5 (que )-1.5 (investigar )]TJ
-0.01 Tw T*
[(anticuerpos )-1.7 (contra )-0.8 (el factor intr)-0.6 (\355nseco )-0.7 (y contra )-0.8 (las c\351lulas )]TJ
0.136 Tw T*
[(parietales, )-1.9 (concomitantemente )-3.8 (el c\341ncer )-1 (g\341strico puede )]TJ
0.149 Tw T*
[(estar )-1.1 (presente )-2.1 (en )-1.1 (el )-0.7 (10%. )-1.5 (El tratamiento )-2.8 (en )-1.2 (estos casos )]TJ
0.045 Tw T*
[(es por )0.7 (v\355a )-0.6 (paren)-1 (teral )-0.9 (y sin inter)-1.2 (rupci\363n)]TJ
-0.03 Tc 5 0 0 5 208.119 612.7658 Tm
( \(19,20\))Tj
0 Tc 9 0 0 9 224.6452 608.7658 Tm
[(.La )-1 (evaluaci\363n )]TJ
0.01 Tw -19.606 -1 Td
[(cl\355nica )-1.7 (de )-0.8 (pacien)-1.6 (tes )-1.1 (con )-0.6 (deficie)-1 (ncia )-1.4 (de )-1 (vitamina )-2.2 (B12 )-1.2 (debe )309.9 ( )]TJ
0.203 Tw T*
[(incluir )-1 (una )-1 (historia de )-0.8 (consumo de )-0.7 (f\341rmacos, b\372squeda )]TJ
0.032 Tw T*
[(de )-0.6 (s\355ndrome de )-0.6 (mala )-0.8 (absorci\363n e investigaci\363n )-1.8 ( de )-0.6 (causas )]TJ
0.175 Tw T*
[(autoinmunes )-2.9 ( de )-0.9 (deficiencia )-2.4 (de )-1 (vitamina )-2.2 (B12, )-1.3 (tal )-1.2 (como )]TJ
0 Tw T*
(anemia perniciosa)Tj
-0.03 Tc 5 0 0 5 121.3491 567.7658 Tm
( \(21\))Tj
0 Tc 9 0 0 9 131.0215 563.7658 Tm
(.)Tj
0.066 Tw -9.204 -2 Td
[(En )-0.6 (conclusi\363n )-0.9 (presentamos )-1.8 (el )-0.9 (caso de )-1 (un )-1.3 (paciente )-3.1 (adulto )]TJ
0.116 Tw T*
[(mayor con )-0.6 (un )-1.3 (cuadro )-0.7 (cl\355nico )-1 (de )-1 (demencia )-2.6 (por d\351ficit )-1.6 (de )]TJ
0.21 Tw T*
[(vitamina )-2 (B12, )-1.2 (cuya )-1.3 (reversibilidad )-1.1 (fue )-0.7 (observada tras )-0.6 (la )]TJ
0.324 Tw T*
[(reposici\363n de )-0.9 (cobalamina )-1.8 (y \341cido f\363lico )0.6 (intramuscular )]TJ
-0.094 Tw T*
[(diariamente )-3 (por una )-1.5 (semana )-1.8 (, luego )-0.7 (cobalamina )-1.9 (IM )-1.1 (semanal )]TJ
0.178 Tw T*
[(y )-0.7 (\341cido f\363lico por v\355a )-0.9 (oral, du)-0.6 (rante )-1.9 (su )-0.7 (hospitalizaci\363n )-1.9 (, )]TJ
0.031 Tw T*
[(es importante )-2 (valorar cambios del estado )-0.7 (mental )-1.6 (por )0.7 (m\341s )]TJ
0.051 Tw T*
[(sutiles )-1.3 (que )-1.1 (fuese)-0.6 (n )-0.8 (a )-0.7 (fin de )-0.9 ( no catalogar )-1.1 (al )-0.7 (anciano )-1.7 (como )]TJ
-0.051 Tw T*
[(portador de )-0.7 (una )-1.2 (enfermedad )-1.8 (neu)-1.1 (rodegenerativa )-2 (o vascular )]TJ
0 Tw T*
(como causa de s\355ndrome demencial.)Tj
0 1 0.65 0.47 k
/GS0 gs
/TT1 1 Tf
0 -2.311 TD
(REFERENCIAS BIBLIOGR\301FICAS)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
-0.02 Tc 0.031 Tw 8 0 0 8 48.189 423.9658 Tm
(1.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Hughes C, W)55.6 (ard M, Hoey L, McNulty H. V)17.6 (itamin B12 and ageing:)-20.2 ( )]TJ
0.236 Tw 0 -1.25 TD
[(current )-0.6 (issues )-0.6 (and )-0.6 (interaction )-0.6 (with )-0.6 (folate. )-0.6 (annals )-0.6 (of )-0.6 (Clinical)-19.9 ( )]TJ
0 Tw T*
[(Biochemistry)121.9 (. 2013; 50\(4\): 315-29.)]TJ
0.239 Tw -1.772 -1.25 Td
(2.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Moore E, Mander )55.1 (A, )55.2 (Ammes D, Carne R, Sanders K, W)55.6 (atters)-19.7 ( )]TJ
0.494 Tw T*
[(D. Cognitive impairment and vitamin B12: a review)105.8 (. int)-20.5 ( )]TJ
0 Tw T*
(Psichogeriatric. 2012;24\(4\):541-56.)Tj
0.27 Tw -1.772 -1.25 Td
(3.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(R)40.5 (obert C, David L. vitamin B12 deficiency)121.9 (. american Family)-20.2 ( )]TJ
0 Tw T*
[(P)47.3 (hysician. 2003; 67\(5\): 979-86.)]TJ
0.148 Tw -1.772 -1.25 Td
(4.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(P)47.3 (enninx B, Guralnik J, Ferrucci L, Fried L, )54.9 (Alien R, Stabler S.)-20.2 ( )]TJ
0.333 Tw T*
[(V)17.7 (itamin B12 deficiency and depression and aging sttudy in)-20.4 ( )]TJ
0.154 Tw T*
[(physical disabled older women : epidemiologic evidence from)-20.1 ( )]TJ
0 Tw T*
[(the wome\222ns health. )54.9 (Am J Psychiatry)121.9 (. 2000; 157\(5\): 715-21.)]TJ
0.108 Tw -1.772 -1.25 Td
(5.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Silver H. V)17.7 (itamin B12 levels are low in hospitalised psychiatric)-20.2 ( )]TJ
0 Tw T*
(patient. J Psyquiatric. 2000; 37\(1\):41-5.)Tj
0.286 Tw -1.772 -1.25 Td
(6.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Goebels )-0.7 (N, )-0.7 (Soyka )-0.8 (M. )-0.7 (dementia )-0.7 (associated )-0.8 (with )-0.7 (vitamin )-0.7 (B12)-20.4 ( )]TJ
0.376 Tw T*
[(deficiency : presentation of two cases and review of the)-20.5 ( )]TJ
0 Tw T*
(literature. J Neuropsychiatry Clin Neurosci. 2000;12\(3\):389-95.)Tj
0.034 Tw -1.772 -1.25 Td
(7.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Andres E, Loukili N, Noel E, Kaltenbach G, )54.9 (Abdelgheni M, P)47.2 (errin)-20.4 ( )]TJ
0.053 Tw T*
[(A, et al.V)17.7 (itamin B12 \(cobalamin\) deficiency in elderly patients.)-20.2 ( )]TJ
0 Tw T*
[(CMAJ)0.5 (. 2004;171\(3\): 251-9.)]TJ
0.065 Tw -1.772 -1.25 Td
(8.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(K)31.6 (ibirige D, W)45.9 (ekesa C, Kaddu-Mukasa M, W)55.7 (aiswa M. V)17.7 (itamin B12)-20.4 ( )]TJ
0.29 Tw T*
[(deficiency )-0.6 (presenting )-0.6 (as )-0.6 (an acute )-0.6 (confusional state: a )-0.6 (case)-20.4 ( )]TJ
0 Tw T*
[(report and review of literature. )54.9 (Afr Health Sci.2013;13\(3\):850\2262)]TJ
29.409 59.692 Td
(9.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Burns )54.9 (A, Ilffe S. )54.9 (Alzheimer)14 (\222)68.7 (s disease. BMJ)0.5 (. 2009; 338:b158.)]TJ
0.149 Tw -1.772 -1.25 Td
(10.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(R)28.8 (usher D, P)47.3 (awlak R. )55.1 (A)55.4 ( review of 89 published Case studies of)-19.6 ( )]TJ
0 Tw T*
[(V)17.7 (itamin B12. J Hum Nutr Food Sci. 2013;1\(2\):1008.)]TJ
0.151 Tw -1.772 -1.25 Td
(11.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Favrat B, V)78.2 (aucher P)195.7 (, Herzig L, Burnand B, )54.8 (Ali G, Boulat O, et)-20.5 ( )]TJ
0.052 Tw T*
[(al. )-0.6 (Oral )-0.6 (vitamin B12 )-0.6 (for patients )-0.6 (suspected )-0.6 (of subtle cobalamin)-20.3 ( )]TJ
-0.002 Tw T*
[(deficiency:a multicentre pragmatic randomized controlled trial.)-20.1 ( )]TJ
0 Tw T*
[(BMC Fam P)47.3 (ract. 2011; 12: 2.)]TJ
0.205 Tw -1.772 -1.25 Td
(12.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Lerner V)146.1 (, Kanevsky M. )54.9 (Acute dementia with delilrium due to)-19.6 ( )]TJ
0.174 Tw T*
[(vitamin b12 deficiency : a case report. Int J Psychiatry Med.)-20.2 ( )]TJ
0 Tw T*
(2002; 32\(2\): 215-20.)Tj
0.039 Tw -1.772 -1.25 Td
(13.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(De P)47.2 (az R, Hernandez-Navarro F)180.3 (, R)40.5 (einoso-P)47.2 (erez F)180.2 (, Rivas-P)47.3 (ollmara)-20.3 ( )]TJ
0.227 Tw T*
[(I. Diagnostico y tratamiento de las anemias megaloblasticas.)-20.2 ( )]TJ
0 Tw T*
(Medicine. 2008; 10\(20\):1326-33.)Tj
-0.048 Tw -1.772 -1.25 Td
(14.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Carmel R. How I treat cobalamin \(vitamin B12\) deficiency)121.9 (. Blood.)-20.2 ( )]TJ
0 Tw T*
(2008; 112\(6\):2214-21.)Tj
-0.032 Tw -1.772 -1.25 Td
(15.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Schrier S. Etiology and clinical manifestations of vitamin B12 and)-20.2 ( )]TJ
0.086 Tw T*
[(folic acid deficiency)121.9 (. En UpT)124.9 (oDate, Mentzer W \(ed\), UpT)124.9 (oDate,)-20.2 ( )]TJ
0 Tw T*
[(W)55.6 (altham M, 2011.)]TJ
0.147 Tw -1.772 -1.25 Td
(16.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Erkurt M, )55 (A)41.2 (ydogdu I, Dikilitas M, kuku I, Kaya E, Bayraktar N,)-20.2 ( )]TJ
0.231 Tw T*
[(et al. Effect of cyanocobalamin on inmunity in patient with)-20.4 ( )]TJ
0 Tw T*
[(pernicious anemia. Med P)47.2 (rinc P)47.2 (ract. 2008; 17\(2\): 131-5.)]TJ
0.222 Tw -1.772 -1.25 Td
(17.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(OHT)97.6 (A)55.3 ( M. Management)-0.6 ( of anemia in the elderly)121.9 (. JMAJ. 2009;)-20.2 ( )]TJ
0 Tw T*
(52\(4\): 219-23.)Tj
0.364 Tw -1.772 -1.25 Td
(18.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Emmanuel )55 (A, Khalid S. Optimal management of pernicious)-19.7 ( )]TJ
0 Tw T*
(anemia. J Blood Med. 2012; 3: 97-103.)Tj
0.073 Tw -1.772 -1.25 Td
(19.)Tj
/Span<>> BDC
( )Tj
EMC
1.772 0 Td
[(Andre E, Loukili N, Noel E, Kaltenbach G, )55.5 (Abdelgheni M, P)47.2 (errin)-20.4 ( )]TJ
0.052 Tw T*
[(A, et al.V)17.6 (itamin B12 deficiency in Elderly P)47.3 (atients. CMA)97.3 (T)166.4 (. 2004;)-20.1 ( )]TJ
0 Tw T*
(171\(3\): 251-9.)Tj
0 1 0.65 0.47 k
/GS0 gs
/TT2 1 Tf
0 Tc -1.772 -2.5 Td
(Fuentes de financiamiento:)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 -1.2 TD
[(Este art\355culo ha sido financiado por el autor)128.2 (.)]TJ
0 1 0.65 0.47 k
/GS0 gs
/TT2 1 Tf
0 -2.45 TD
(Conflictos de inter\351s:)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
0 -1.2 TD
(El autor declara no tener ning\372n conflicto de inter\351s.)Tj
0 1 0.65 0.47 k
/GS0 gs
/TT2 1 Tf
0 -2.45 TD
(Correspondencia:)Tj
0 0 0 1 k
/GS1 gs
/TT0 1 Tf
-0.01 Tc 0 -1.25 TD
(Leonidas Carrillo \321a\361ez)Tj
T*
[(Direcci\363n: Calle los Ficus 136 Urbanizaci\363n Jardines V)17.7 (iru -)-10.2 ( )]TJ
0.01 Tw T*
(Bellavista)Tj
0 Tw T*
[(T)124.9 (el\351fono: 945330799)]TJ
T*
[(Correo electr\363nico: lchcarn@)0.5 (yahoo.es)]TJ
ET
0 1 0.65 0.47 k
/GS0 gs
330.236 217.906 170.079 36.851 re
f
BT
0 0 0 0 k
0 Tc -0.057 Tw 9 0 0 9 351.9404 238.8535 Tm
[(R)40.5 (ecibido: )-1.1 (27 )-1 (de )-0.8 (febrero de )-0.8 (2017)]TJ
0 Tw 0 -1.222 TD
(Aprobado: 03 de mayo de 2017)Tj
0 0 0 1 k
/GS1 gs
0.03 Tc -12.95 55.52 Td
[(Leonidas Carrillo \321a\361ez, P)47.2 (amela Carrillo Garc\355a, Mirna V)78.2 (aras \301lvarez,)29.9 ( )]TJ
11.606 -1.111 Td
[(Fernanda )54.9 (Aliaga C\363rdova, C\351sar Chian Garc\355a)]TJ
ET
endstream
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/TT0 1 Tf
0.04 Tc 0 Tw 0 Ts 100 Tz 0 Tr 9 0 0 9 439.4828 32.9076 Tm
(abril - junio 2017)Tj
ET
endstream
endobj
35 0 obj
<>
endobj
36 0 obj
<>
endobj
37 0 obj
<>stream
H\ϊ0y9T)Plh2vk1=;qJ6%}dF&|j1`8Owz+QqZj윐dn9ae slNzq+荽n ۻs?8
@UƁtj5&,;)>甋Qu
}go(ʄVV%~PߝeIBL}ߧi9\09kYGM~d>F>1"u%/S<Ł>Q}|MSwm~Ni'~ ZU
endstream
endobj
38 0 obj
<>stream
HU TsDA@{21LQP'@F8D*iCrsDs"r5}^Zo^k}s9 ̀ Ɔ3R.d]P4 `G}\ctwV.`fM7
^\z椴6Mr2RR-dvbYOtGܼ{>9&9 znJʳ^97RݶG>G0]klb3֜TA
^L\rM*bR{.~Gc
0n6ن^x1ɉ
tNM$Qz>w4ݥkm7:uyzm?}66̖&!4}Yа-jպMvã9KnQcѳW>}"vAO2t$HNIMK9jtfVq'L̛4yig̜5{NSs/\p⧗,}/eWʟV^vݫ76Moo~-[m]-۷>r?g'?ǩg*%J^
әghW^O6M7M4- \P: 5
b4ZF'#ҰZ5cì
syEY\,,- K%ƒhI
.~#xs7.7θ,7H,sbZ]DHדW0XZ%78lːXoXRX Xv{5`ّ6/֖[n֤ȭ